Molecule Details
InChIKeyJJWLXRKVUJDJKG-VIFPVBQESA-N
Compound NameBms-863233
Canonical SMILESO=c1[nH]c([C@@H]2CCCN2)nc2c1oc1ccc(Cl)cc12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)6
Pfam Stratification Cross-Family
Avg pChEMBL7.12
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12357
Drug NameBMS-863233
CAS Number1169558-38-6
Groups investigational
ATC Codes nan
DescriptionBMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.

Cross-references: BindingDB: 50383714 CHEMBL2030402 ChemSpider: 28508270 PDB: 0SX PubChem:57899889 PubChem:347828610 ZINC: ZINC000084668615
Target Activities (6)
Target Gene Organism Category Pfam pChEMBL Type Source
P19784 CSNK2A2 Homo sapiens Human PF00069 7.7 Kd ChEMBL
Q13627 DYRK1A Homo sapiens Human PF00069 7.4 Kd ChEMBL
P11309 PIM1 Homo sapiens Human PF00069 7.4 IC50 ChEMBL;BindingDB
O00311 CDC7 Homo sapiens Human PF00069 6.9 IC50 ChEMBL;BindingDB
P67870 CSNK2B Homo sapiens Human PF01214 6.7 IC50 ChEMBL
P68400 CSNK2A1 Homo sapiens Human PF00069 6.7 IC50 ChEMBL
DrugBank Target Actions (1)
Target Gene Target Name Action Type
O00311 CDC7 Cell division cycle 7-related protein kinase modulator targets